trending Market Intelligence /marketintelligence/en/news-insights/trending/-Prot2_-JIJlbJ2iEXrOWw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Sun Pharma fiscal Q1 profit up 31.2% YOY

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Sun Pharma fiscal Q1 profit up 31.2% YOY

Sun Pharmaceutical Industries Ltd. said its profit for the fiscal first quarter ended June 30 climbed 31.2% year over year.

The Mumbai-based maker of generic drugs said net profit for the quarter totaled 13.87 billion Indian rupees, or 5.78 rupees per share, up from 10.57 billion rupees, or 4.41 rupees per share, in the year-earlier period.

Total revenue grew 15.9% on an annual basis to 83.74 billion rupees from 72.24 billion rupees.

Research and development expenses decreased 16.1% year over year to 4.07 billion rupees from 4.85 billion rupees.

As of Aug. 12, US$1 was equivalent to 71.28 Indian rupees.